Overview
Updated 14 Jul 2026
Toni K. Choueiri is Director, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute. The public record shows 2,494 publications with 128,964 citations (h-index 152), centered on Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers, Bladder and Urothelial Cancer Treatments. It also documents an investigator role on 12 registered clinical trials, 7 NIH-funded awards (2015–2026).
- Most recent indexed publication: 2026 · The New England journal of medicine
- Top research focus: Renal cell carcinoma treatment
- 12 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 134 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 907.
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- As FDA ODAC member
voted on/commented on drug approval matters (e.g., recommended PTEN expression ≥90% cutoff for capivasertib indication due to toxicity concerns; voted on camizestrant for HR+/HER2- breast cancer)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 12 registered studies on ClinicalTrials.gov. The most recent:
- Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC
Sponsor: AstraZeneca
InvestigatorPhase 3Active, not recruitingNCT05043090 - ABEMA Alone or in COMBO With MK-6482
Sponsor: Dana-Farber Cancer Institute
InvestigatorPhase 1CompletedNCT04627064 - Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study)
Sponsor: Toni Choueiri, MD
InvestigatorPhase 2Active, not recruitingNCT03203473
Industry payments
18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 14 Jul 2026
7 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Optimizing neoadjuvant/adjuvant anti-PD-1 therapy for localized Renal Cell Carcinoma
Brigham and Women'S Hospital
FY2026$740,020R01CA308071 - Tissue-based biomarkers of anti-PD-1-based therapy in metastatic renal cell carcinoma
Dana-Farber Cancer Inst
FY2026$713,011R01CA266424
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma.
The New England journal of medicine
2026 - Long-term follow-up from the OMNIVORE trial: response-adaptive nivolumab and ipilimumab in advanced renal cell carcinoma.
Journal for immunotherapy of cancer
2026
Most-cited worksby citation count (OpenAlex)
- 01The Immune Landscape of Cancer6,200 citations2018
- 02Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma5,896 citations2015
- 03Post-acute COVID-19 syndrome5,025 citations2021
- 04Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma4,647 citations2018
- 05Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma3,395 citations2017
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →connection.asco.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →labs.dana-farber.org ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗
Secondary affiliationsappointments beyond the home institution
- Medical Director
International Strategic Initiatives, Dana-Farber Cancer Institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - Co-leader
Kidney Cancer Program, Dana-Farber/Harvard Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dana-farber.org ↗ - Attending Physician
Medical Oncology, Brigham and Women's Hospital
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →urotoday.com ↗
- Regular video contributor/author
OncLive (multiple interviews on RCC treatment developments)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗ - Interview
CancerNetwork - 'How New Data Impact the Standard of Care for RCC'
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cancernetwork.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/toni-choueiri-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/toni-choueiri-924b9614b
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/profile/Toni-Choueiri
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Other
themedicinementors.libsyn.com/the-true-mark-of-success-with-dr-toni-choueiri
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →themedicinementors.libsyn.com ↗ - Instagram
instagram.com/curetoday/reel/DAQqvqRvZcf
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Instagram
instagram.com/danafarber/p/CqTBEowufVF
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Scott Solomon, MD
Brigham and Women's Hospital
- 2,109
- publications
- 190
- h-index
- 13
- trials
Muthiah Vaduganathan, MD, MPH
Brigham and Women's Hospital
- 1,168
- publications
- 101
- h-index
- 1
- trial
Bartolome Celli, MD
Brigham and Women's Hospital
- 809
- publications
- 134
- h-index
- 2
- trials
Michelle Petri, MD
Brigham and Women's Hospital
- 985
- publications
- 137
- h-index
- 10
- trials